A detailed history of Mackenzie Financial Corp transactions in Pfizer Inc stock. As of the latest transaction made, Mackenzie Financial Corp holds 891,118 shares of PFE stock, worth $24.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
891,118
Previous 1,784,696 50.07%
Holding current value
$24.5 Million
Previous $49.5 Million 49.66%
% of portfolio
0.04%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $22.6 Million - $26.4 Million
-893,578 Reduced 50.07%
891,118 $24.9 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $1.76 Million - $2.02 Million
67,795 Added 3.95%
1,784,696 $49.5 Million
Q4 2023

Jan 30, 2024

BUY
$26.13 - $33.94 $12.8 Million - $16.6 Million
488,479 Added 39.76%
1,716,901 $49.4 Million
Q3 2023

Oct 25, 2023

SELL
$32.09 - $37.51 $10.1 Million - $11.8 Million
-315,726 Reduced 20.45%
1,228,422 $40.7 Million
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $5.9 Million - $6.82 Million
163,225 Added 11.82%
1,544,148 $56.6 Million
Q1 2023

Apr 24, 2023

SELL
$39.39 - $51.28 $2.61 Million - $3.39 Million
-66,163 Reduced 4.57%
1,380,923 $56.3 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $5.64 Million - $7.37 Million
-135,151 Reduced 8.54%
1,447,086 $74.2 Million
Q3 2022

Oct 07, 2022

BUY
$43.76 - $53.42 $848,768 - $1.04 Million
19,396 Added 1.24%
1,582,237 $69.2 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $10.5 Million - $12.4 Million
225,423 Added 16.86%
1,562,841 $81.9 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $3.65 Million - $4.53 Million
79,887 Added 6.35%
1,337,418 $69.2 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $4.68 Million - $6.93 Million
-113,211 Reduced 8.26%
1,257,531 $74.3 Million
Q3 2021

Nov 08, 2021

BUY
$39.25 - $50.42 $4.13 Million - $5.3 Million
105,161 Added 8.31%
1,370,742 $59 Million
Q2 2021

Aug 11, 2021

SELL
$35.91 - $40.68 $7.41 Million - $8.39 Million
-206,251 Reduced 14.01%
1,265,581 $49.6 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $17.2 Million - $19.4 Million
514,496 Added 53.74%
1,471,832 $53.3 Million
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $1.05 Million - $1.34 Million
31,421 Added 3.39%
957,336 $35.2 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $5.73 Million - $6.73 Million
-180,559 Reduced 16.32%
925,915 $34 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $3.54 Million - $4.29 Million
-117,474 Reduced 9.6%
1,106,474 $34.3 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $15.9 Million - $22.7 Million
587,199 Added 92.22%
1,223,948 $37.9 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $3.69 Million - $4.19 Million
-112,035 Reduced 14.96%
636,749 $24.9 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $1.5 Million - $1.95 Million
-46,215 Reduced 5.81%
748,784 $26.9 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $37.1 Million - $41.7 Million
-1,003,372 Reduced 55.79%
794,999 $34.4 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $63.8 Million - $70.1 Million
-1,700,304 Reduced 48.6%
1,798,371 $76.4 Million
Q4 2018

Feb 06, 2019

BUY
$38.47 - $43.86 $15.5 Million - $17.7 Million
402,790 Added 13.01%
3,498,675 $153 Million
Q3 2018

Nov 15, 2018

SELL
$34.47 - $41.81 $54.8 Million - $66.5 Million
-1,590,665 Reduced 33.94%
3,095,885 $136 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $99.9 Million - $106 Million
-3,028,485 Reduced 39.25%
4,686,550 $170 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $120 Million - $139 Million
-3,766,953 Reduced 32.81%
7,715,035 $274 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $381 Million - $404 Million
11,442,753 Added 29164.66%
11,481,988 $416 Million
Q3 2017

Nov 13, 2017

SELL
$31.0 - $34.15 $845,091 - $930,963
-27,261 Reduced 41.0%
39,235 $1.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
66,496
66,496 $2.23 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.